Cephalothin Pregnancy and Breast Feeding Warnings

Cephalothin is also known as: Keflin

Cephalothin Pregnancy Warnings

Cephalothin has been assigned to pregnancy category B. Animal studies failed to reveal evidence of fetal harm. There are no controlled data in human pregnancies. Cephalothin should only be given during pregnancy when need has been clearly established.

There are no reports of adverse fetal effects of cephalothin during human pregnancy. It has been used safely during all stages of gestation to treat a variety of conditions. In one study, using cephalothin 1 gram intramuscularly, the average peak umbilical cord cephalothin level was 2.8 mcg/mL between one and two hours after dosing. This represented 16% of the corresponding maternal serum level.

Cephalothin Lactation Warnings

Cephalothin is excreted into human milk in small amounts. Adverse effects in the nursing infant are unlikely. Other cephalosporins have been classified as compatible with breast-feeding by the American Academy of Pediatrics.

In one study of six women who received cephalothin 1 gram intravenously, the average peak milk cephalothin level was 0.51 mcg/mL between one and two hours after dosing. The average milk to maternal plasma drug level ratios were 0.073, 0.260, and 0.500 at 1, 2, and 3 hours after dosing, respectively. While these levels are extremely low, some experts warn against the unknown direct effects to the nursing infant, modification of the infant's bowel flora, and difficulty in the interpretation of culture results in the evaluation of a suspected infection.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.